This site is intended for healthcare professionals only
The total cost of COVID-19-related expenses pharmacy owners have claimed for is “significantly higher” than the £120 million cap the government had originally offered, PSNC has said.
In June, the Pharmaceutical Services Negotiating Committee (PSNC) announced that contractors would have until August 15 to make claims for COVID-19 related costs they incurred between March 2020 and March 2021.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
The National Pharmacy Association (NPA) has announced that it is advising its 6,000 member pharmacies to limit services and reduce opening hours in protest against “unsustainable” funding.
Due to shortages in coal tar scalp ointment, the DHSC has asked the manufacturer of an equivalent product - Sebco - to provide increased stock levels to support patients during this time.
Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.
Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.
Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.
